AXM Pharma Receives Approval from Chinese Food and Drug Administration to Market New Treatment for Diabetes; Drug Demonstrates Efficacy in Clinical Activities
12/23/2005 9:22AM - Business Wire
AXM Receives Notification Letter from American Stock Exchange; Company's Common Stock to Continue to be Listed
12/23/2005 9:20AM - Business Wire